... of the company's stock worth $175,001,000 after buying an additional 3,095,804 shares during the last quarter. Ardsley Advisory Partners lifted its position in shares of TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners ...
https://sportsperspectives.com/2018/05/24/zacks-brokerages-anticipate-therapeuticsmd-inc-txmd-will-post-quarterly-sales-of-4-13-million.html
No comments:
Post a Comment